TREATMENT OF SYSTEMIC FUNGAL-INFECTIONS WITH LIPOSOMAL AMPHOTERICIN-B

被引：158
|
作者：
LOPEZBERESTEIN, G
BODEY, GP
FAINSTEIN, V
KEATING, M
FRANKEL, LS
ZELUFF, B
GENTRY, L
MEHTA, K
机构：
[1] ST LUKES HOSP,DEPT INFECT DIS,HOUSTON,TX
[2] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT HEMATOL,HOUSTON,TX 77030
[3] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT PEDIAT,HOUSTON,TX 77030
[4] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT INTERNAL MED,DIV MED,INFECT DIS SECT,HOUSTON,TX 77030
来源：
ARCHIVES OF INTERNAL MEDICINE | 1989年 / 149卷 / 11期
关键词：
D O I：
10.1001/archinte.149.11.2533
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：2533 / 2536
页数：4
相关论文
共 50 条
  • [21] LIPOSOMAL AMPHOTERICIN-B (AMBISOME) THERAPY IN INVASIVE FUNGAL-INFECTIONS - EVALUATION OF UNITED-KINGDOM COMPASSIONATE USE DATA
    NG, TTC
    DENNING, DW
    ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (10) : 1093 - 1098
  • [22] THE EFFICACY OF ITRACONAZOLE AGAINST SYSTEMIC FUNGAL-INFECTIONS IN NEUTROPENIC PATIENTS - A RANDOMIZED COMPARATIVE-STUDY WITH AMPHOTERICIN-B
    VANTWOUT, JW
    NOVAKOVA, I
    VERHAGEN, CAH
    FIBBE, WE
    DEPAUW, BE
    VANDERMEER, JWM
    MEDIZINISCHE KLINIK, 1991, 86 : 11 - 13
  • [23] THE EFFICACY OF ITRACONAZOLE AGAINST SYSTEMIC FUNGAL-INFECTIONS IN NEUTROPENIC PATIENTS - A RANDOMIZED COMPARATIVE-STUDY WITH AMPHOTERICIN-B
    VANTWOUT, JW
    NOVAKOVA, I
    VERHAGEN, CAH
    FIBBE, WE
    DEPAUW, BE
    VANDERMEER, JWM
    JOURNAL OF INFECTION, 1991, 22 (01) : 45 - 52
  • [24] REDUCTION OF SYSTEMIC FUNGAL-INFECTIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, NEUTROPENIA, AND PROLONGED FEVER BY EARLY AMPHOTERICIN-B THERAPY
    ZIMMERMANNHOSLI, MB
    STAHEL, RA
    VOGT, P
    OELZ, O
    KLINISCHE WOCHENSCHRIFT, 1988, 66 (20): : 1010 - 1014
  • [25] WHICH IS THE MOST APPROPRIATE DOSAGE OF LIPOSOMAL AMPHOTERICIN-B (AMBISOME) FOR THE TREATMENT OF FUNGAL-INFECTIONS IN INFANTS OF VERY-LOW-BIRTH-WEIGHT - REPLY
    LACKNER, H
    URBAN, C
    PEDIATRICS, 1993, 91 (06) : 1218 - 1218
  • [26] AEROSOLIZED LIPOSOMAL AMPHOTERICIN-B FOR TREATMENT OF PULMONARY AND SYSTEMIC CRYPTOCOCCUS-NEOFORMANS INFECTIONS IN MICE
    GILBERT, BE
    WYDE, PR
    WILSON, SZ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (07) : 1466 - 1471
  • [27] SELECTIVE AMPHOTERICIN-B PROPHYLAXIS IN THE REDUCTION OF FUNGAL-INFECTIONS AFTER LIVER-TRANSPLANT
    MORA, NP
    KLINTMALM, G
    SOLOMON, H
    GOLDSTEIN, RM
    GONWA, TA
    HUSBERG, BS
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (01) : 154 - 155
  • [28] PROPHYLACTIC USE OF LIPOSOMAL AMPHOTERICIN-B (AMBISOME) AGAINST FUNGAL-INFECTIONS - A RANDOMIZED TRIAL IN BONE-MARROW TRANSPLANT RECIPIENTS
    TOLLEMAR, J
    RINGDEN, O
    ANDERSSON, S
    SUNDBERG, B
    LJUNGMAN, P
    SPARRELID, E
    TYDEN, G
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 1495 - 1497
  • [29] CHEMOPROPHYLAXIS OF FUNGAL-INFECTIONS IN GRANULOCYTOPENIC PATIENTS USING FLUCONAZOLE VS ORAL AMPHOTERICIN-B
    MEUNIER, F
    AOUN, M
    JANSSENS, M
    DEKOSTER, C
    PAESMANS, M
    DRUG INVESTIGATION, 1991, 3 (04): : 258 - 265
  • [30] COMPARISON OF LIPOSOMAL AMPHOTERICIN-B TO AMPHOTERICIN-B FOR TREATMENT OF MURINE CRYPTOCOCCAL MENINGITIS
    ALBERT, MM
    STAHLCARROLL, TL
    LUTHER, MF
    GRAYBILL, JR
    JOURNAL DE MYCOLOGIE MEDICALE, 1995, 5 (01): : 1 - 6
12345